Natural Killer (NK) Cell Therapeutics Market Size, Share & Trends Analysis Report By Product (CAR-NK Cell Therapies, NK Cell-directed Antibodies), By Indication (Oncology, Infectious Diseases, Autoimmune Diseases, Gastrointestinal Diseases, Other Indications), By End User (Hospitals & Clinics, Research & Academic Institutes, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
  7. North America Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  8. Europe Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  9. APAC Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  10. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  11. LATAM Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  12. Competitive Landscape
    1. Natural Killer (NK) Cell Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Fate Therapeutics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Nkarta Therapeutics
    3. Century Therapeutics
    4. Glycostem Therapeutics
    5. Artiva Biotherapeutics
    6. Affimed N.V.
    7. Innate Pharma
    8. Dragonfly Therapeutics
    9. GT Biopharma
    10. ImmunityBio
    11. Acepodia
    12. Bristol-Myers Squibb
    13. Novartis
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Regions - 2022-2034 (USD Million)

Table 2: Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 3: Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 4: Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 5: North America Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 6: North America Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 7: North America Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 8: North America Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 9: U.S. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 10: U.S. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 11: U.S. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 12: Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 13: Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 14: Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 15: Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 16: Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 17: Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 18: Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 19: U.K. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 20: U.K. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 21: U.K. Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 22: Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 23: Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 24: Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 25: France Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 26: France Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 27: France Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 28: Spain Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 29: Spain Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 30: Spain Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 31: Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 32: Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 33: Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 34: Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 35: Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 36: Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 37: Nordic Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 38: Nordic Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 39: Nordic Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 40: Benelux Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 41: Benelux Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 42: Benelux Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 43: Rest of Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 44: Rest of Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 45: Rest of Europe Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 46: APAC Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 47: APAC Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 48: APAC Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 49: APAC Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 50: China Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 51: China Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 52: China Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 53: Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 54: Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 55: Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 56: Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 57: Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 58: Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 59: India Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 60: India Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 61: India Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 62: Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 63: Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 64: Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 65: Taiwan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 66: Taiwan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 67: Taiwan Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 68: South East Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 69: South East Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 70: South East Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 71: Rest of Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 72: Rest of Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 73: Rest of Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 74: Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 75: Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 76: Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 77: Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 78: UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 79: UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 80: UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 81: Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 82: Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 83: Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 84: Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 85: Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 86: Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 87: South Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 88: South Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 89: South Africa Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 90: Egypt Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 91: Egypt Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 92: Egypt Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 93: Nigeria Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 94: Nigeria Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 95: Nigeria Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 96: Rest of MEA Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 97: Rest of MEA Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 98: Rest of MEA Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 99: LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 100: LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 101: LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 102: LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 103: Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 104: Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 105: Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 106: Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 107: Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 108: Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 109: Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 110: Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 111: Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 112: Chile Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 113: Chile Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 114: Chile Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 115: Colombia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 116: Colombia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 117: Colombia Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

Table 118: Rest of LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Million)

Table 119: Rest of LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By Indication - 2022-2034 (USD Million)

Table 120: Rest of LATAM Natural Killer (NK) Cell Therapeutics Market Size and Forecast By End User - 2022-2034 (USD Million)

We are featured on: